Click here to get full coverage on Royals hold Witt Jr. (Grade 1 MCL sprain) out of lineup vs. Cardinals - MLB.com

Royals hold Witt Jr. (Grade 1 MCL sprain) out of lineup vs. Cardinals  MLB.com

Royals hold Witt Jr. (Grade 1 MCL sprain) out of lineup vs. Cardinals - MLB.com

Click here to get full coverage on Bobby Witt Jr. has a Grade 1 MCL sprain - Royals Review

Bobby Witt Jr. has a Grade 1 MCL sprain  Royals Review

Bobby Witt Jr. has a Grade 1 MCL sprain - Royals Review

Click here to get full coverage on Bobby Witt Jr. out of Royals' lineup with grade-1 MCL sprain - ESPN

Bobby Witt Jr. out of Royals' lineup with grade-1 MCL sprain  ESPN

Bobby Witt Jr. out of Royals' lineup with grade-1 MCL sprain - ESPN

Click here to get full coverage on Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain - USA Today

Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain  USA Today

Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain - USA Today

Click here to get full coverage on Bobby Witt Jr. has a Grade 1 MCL sprain - Yahoo Sports

Bobby Witt Jr. has a Grade 1 MCL sprain  Yahoo Sports

Bobby Witt Jr. has a Grade 1 MCL sprain - Yahoo Sports

Click here to get full coverage on Royals' Bobby Witt: Diagnosed with Grade 1 MCL sprain - CBS Sports

Royals' Bobby Witt: Diagnosed with Grade 1 MCL sprain  CBS Sports

Royals' Bobby Witt: Diagnosed with Grade 1 MCL sprain - CBS Sports

Click here to get full coverage on Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - Toronto Star

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain  Toronto Star

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - Toronto Star

Click here to get full coverage on Real-World Liso-cel Safety: Key Nursing Insights for R/R MCL Management - Oncology Nursing News

Real-World Liso-cel Safety: Key Nursing Insights for R/R MCL Management  Oncology Nursing News

Real-World Liso-cel Safety: Key Nursing Insights for R/R MCL Management - Oncology Nursing News

Click here to get full coverage on First-Line/Maintenance Ibrutinib Improves Survival in TP53-Mutated MCL - CancerNetwork

First-Line/Maintenance Ibrutinib Improves Survival in TP53-Mutated MCL  CancerNetwork

First-Line/Maintenance Ibrutinib Improves Survival in TP53-Mutated MCL - CancerNetwork

Click here to get full coverage on Billionaire Jeffrey Cheah’s Sunway MCL, Partner Offer Top Bid Of $581 Million For Prime Singapore Site - Forbes

Billionaire Jeffrey Cheah’s Sunway MCL, Partner Offer Top Bid Of $581 Million For Prime Singapore Site  Forbes

Billionaire Jeffrey Cheah’s Sunway MCL, Partner Offer Top Bid Of $581 Million For Prime Singapore Site - Forbes

Click here to get full coverage on Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - The Tribune-Democrat

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain  The Tribune-Democrat

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - The Tribune-Democrat

Click here to get full coverage on Ibrutinib-Containing 1L Therapy Improves Outcomes in Younger Patients With MCL - Clinical Oncology News

Ibrutinib-Containing 1L Therapy Improves Outcomes in Younger Patients With MCL  Clinical Oncology News

Ibrutinib-Containing 1L Therapy Improves Outcomes in Younger Patients With MCL - Clinical Oncology News

Click here to get full coverage on Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - Winnipeg Free Press

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain  Winnipeg Free Press

Bobby Witt Jr. avoids IL stint for now with mild MCL sprain - Winnipeg Free Press

Click here to get full coverage on KIA's Kim Do-hyun Opts for Elbow Surgery - 조선일보

KIA's Kim Do-hyun Opts for Elbow Surgery  조선일보

KIA's Kim Do-hyun Opts for Elbow Surgery - 조선일보

Click here to get full coverage on Bobby Witt Jr. dealing with Grade 1 MCL sprain - NBC Sports

Bobby Witt Jr. dealing with Grade 1 MCL sprain  NBC Sports

Bobby Witt Jr. dealing with Grade 1 MCL sprain - NBC Sports

Click here to get full coverage on Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL - CancerNetwork

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL  CancerNetwork

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL - CancerNetwork

Click here to get full coverage on Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain - Yahoo Sports UK

Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain  Yahoo Sports UK

Bobby Witt Jr. injury update: Royals shortstop has Grade 1 MCL strain - Yahoo Sports UK

Click here to get full coverage on Rocbrutinib Receives Chinese Approval in Relapsed/Refractory MCL - CancerNetwork

Rocbrutinib Receives Chinese Approval in Relapsed/Refractory MCL  CancerNetwork

Rocbrutinib Receives Chinese Approval in Relapsed/Refractory MCL - CancerNetwork

Click here to get full coverage on The McLaren MCL-HY: McLaren’s 2027 FIA World Endurance Championship Hypercar and ultra-exclusive track car revealed - McLaren.com

The McLaren MCL-HY: McLaren’s 2027 FIA World Endurance Championship Hypercar and ultra-exclusive track car revealed  McLaren.com

The McLaren MCL-HY: McLaren’s 2027 FIA World Endurance Championship Hypercar and ultra-exclusive track car revealed - McLaren.com

Click here to get full coverage on Donald (Donnie) McL Barnhill, Jr. - Quinn-McGowen Funeral Home

Donald (Donnie) McL Barnhill, Jr.  Quinn-McGowen Funeral Home

Donald (Donnie) McL Barnhill, Jr. - Quinn-McGowen Funeral Home

Click here to get full coverage on Donald (Donnie) Mcl Barnhill, Jr. Obituary June 5, 2026 - Quinn-McGowen Funeral Home

Donald (Donnie) Mcl Barnhill, Jr. Obituary June 5, 2026  Quinn-McGowen Funeral Home

Donald (Donnie) Mcl Barnhill, Jr. Obituary June 5, 2026 - Quinn-McGowen Funeral Home

Click here to get full coverage on BTK Inhibitor Therapy Makes Inroads Into First-Line MCL - Hematology Advisor

BTK Inhibitor Therapy Makes Inroads Into First-Line MCL  Hematology Advisor

BTK Inhibitor Therapy Makes Inroads Into First-Line MCL - Hematology Advisor

Click here to get full coverage on Stars' Mikko Rantanen finished season with torn MCL - ESPN

Stars' Mikko Rantanen finished season with torn MCL  ESPN

Stars' Mikko Rantanen finished season with torn MCL - ESPN

Click here to get full coverage on Orelabrutinib Earns Australian Approval in Relapsed/Refractory MCL - CancerNetwork

Orelabrutinib Earns Australian Approval in Relapsed/Refractory MCL  CancerNetwork

Orelabrutinib Earns Australian Approval in Relapsed/Refractory MCL - CancerNetwork

Click here to get full coverage on Glofitamab Shows Durable Responses in R/R MCL After 3.5 Years of Follow-Up - AJMC

Glofitamab Shows Durable Responses in R/R MCL After 3.5 Years of Follow-Up  AJMC

Glofitamab Shows Durable Responses in R/R MCL After 3.5 Years of Follow-Up - AJMC

Click here to get full coverage on The MCL Consortium Promotes Growth in Mantle Cell Lymphoma Research - CancerNetwork

The MCL Consortium Promotes Growth in Mantle Cell Lymphoma Research  CancerNetwork

The MCL Consortium Promotes Growth in Mantle Cell Lymphoma Research - CancerNetwork

Click here to get full coverage on Curry to miss at least 2 weeks with MCL sprain - theScore

Curry to miss at least 2 weeks with MCL sprain  theScore

Curry to miss at least 2 weeks with MCL sprain - theScore

Click here to get full coverage on Sonrotoclax Receives Accelerated Approval in Relapsed or Refractory MCL - The ASCO Post

Sonrotoclax Receives Accelerated Approval in Relapsed or Refractory MCL  The ASCO Post

Sonrotoclax Receives Accelerated Approval in Relapsed or Refractory MCL - The ASCO Post

Click here to get full coverage on High Response With Brexu-Cel in R/R MCL: Data Driving FDA Approval - Targeted Oncology

High Response With Brexu-Cel in R/R MCL: Data Driving FDA Approval  Targeted Oncology

High Response With Brexu-Cel in R/R MCL: Data Driving FDA Approval - Targeted Oncology

Click here to get full coverage on McLaren reveals MCL-HY Hypercar – inspired by an icon - FIA WEC

McLaren reveals MCL-HY Hypercar – inspired by an icon  FIA WEC

McLaren reveals MCL-HY Hypercar – inspired by an icon - FIA WEC

Click here to get full coverage on Moving the Needle in MCL: FDA Approvals, Personalized Therapies, and Emerging Agents - OncLive

Moving the Needle in MCL: FDA Approvals, Personalized Therapies, and Emerging Agents  OncLive

Moving the Needle in MCL: FDA Approvals, Personalized Therapies, and Emerging Agents - OncLive

Click here to get full coverage on Should Early-Stage MCL Be Treated Aggressively or Not? - ashpublications.org

Should Early-Stage MCL Be Treated Aggressively or Not?  ashpublications.org

Should Early-Stage MCL Be Treated Aggressively or Not? - ashpublications.org

Click here to get full coverage on MCL Workshop Tackles Tough Issues Facing Rare Lymphoma Subtype - CancerNetwork

MCL Workshop Tackles Tough Issues Facing Rare Lymphoma Subtype  CancerNetwork

MCL Workshop Tackles Tough Issues Facing Rare Lymphoma Subtype - CancerNetwork

Click here to get full coverage on Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma - Nature

Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma  Nature

Inhibition of BIRC5 and MCL-1 as a potential treatment strategy to overcome drug resistance in Mantle Cell Lymphoma - Nature

Click here to get full coverage on Students enjoy final MEMS PTO Carnival at MCL - Bennington Banner

Students enjoy final MEMS PTO Carnival at MCL  Bennington Banner

Students enjoy final MEMS PTO Carnival at MCL - Bennington Banner

Click here to get full coverage on FDA Approves Brexu-Cel for Relapsed/Refractory MCL - OncLive

FDA Approves Brexu-Cel for Relapsed/Refractory MCL  OncLive

FDA Approves Brexu-Cel for Relapsed/Refractory MCL - OncLive

Click here to get full coverage on Studies Use Real-World Data to Evaluate BTK Inhibitors in MCL, CLL; More Options Needed - AJMC

Studies Use Real-World Data to Evaluate BTK Inhibitors in MCL, CLL; More Options Needed  AJMC

Studies Use Real-World Data to Evaluate BTK Inhibitors in MCL, CLL; More Options Needed - AJMC

Click here to get full coverage on Lendeborg vows to play in NCAA final despite MCL, ankle sprains - ESPN

Lendeborg vows to play in NCAA final despite MCL, ankle sprains  ESPN

Lendeborg vows to play in NCAA final despite MCL, ankle sprains - ESPN

Click here to get full coverage on Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma | Leukemia - Nature

Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma | Leukemia  Nature

Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma | Leukemia - Nature

Click here to get full coverage on New Understandings of Treatments, End Points, and Disease Biology Expand MCL Horizons - OncLive

New Understandings of Treatments, End Points, and Disease Biology Expand MCL Horizons  OncLive

New Understandings of Treatments, End Points, and Disease Biology Expand MCL Horizons - OncLive

Click here to get full coverage on FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL - CancerNetwork

FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL  CancerNetwork

FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL - CancerNetwork

Click here to get full coverage on Matthews out for season for Maple Leafs with grade 3 MCL tear - NHL.com

Matthews out for season for Maple Leafs with grade 3 MCL tear  NHL.com

Matthews out for season for Maple Leafs with grade 3 MCL tear - NHL.com

Click here to get full coverage on ‘We’re left with strong units’: MCL owner speaks after closing multiple locations - Fox 59

‘We’re left with strong units’: MCL owner speaks after closing multiple locations  Fox 59

‘We’re left with strong units’: MCL owner speaks after closing multiple locations - Fox 59

Click here to get full coverage on FDA Grants Traditional Approval to Brexucabtagene Autoleucel for Relapsed or Refractory MCL - The ASCO Post

FDA Grants Traditional Approval to Brexucabtagene Autoleucel for Relapsed or Refractory MCL  The ASCO Post

FDA Grants Traditional Approval to Brexucabtagene Autoleucel for Relapsed or Refractory MCL - The ASCO Post

Click here to get full coverage on USA's Hilary Knight says she played with torn MCL at Olympics - ESPN

USA's Hilary Knight says she played with torn MCL at Olympics  ESPN

USA's Hilary Knight says she played with torn MCL at Olympics - ESPN

Click here to get full coverage on MCL Restaurant closing multiple locations in central Indiana, elsewhere - Fox 59

MCL Restaurant closing multiple locations in central Indiana, elsewhere  Fox 59

MCL Restaurant closing multiple locations in central Indiana, elsewhere - Fox 59

Click here to get full coverage on Bruins’ Nikita Zadorov reveals he was playing through a serious knee injury in playoffs - Boston.com

Bruins’ Nikita Zadorov reveals he was playing through a serious knee injury in playoffs  Boston.com

Bruins’ Nikita Zadorov reveals he was playing through a serious knee injury in playoffs - Boston.com

Click here to get full coverage on Trae Young out at least 4 weeks with sprained MCL injury - NBA.com

Trae Young out at least 4 weeks with sprained MCL injury  NBA.com

Trae Young out at least 4 weeks with sprained MCL injury - NBA.com

Click here to get full coverage on Torn MCL for Mikko Rantanen highlights Stars laundry list of injuries - Dallas News

Torn MCL for Mikko Rantanen highlights Stars laundry list of injuries  Dallas News

Torn MCL for Mikko Rantanen highlights Stars laundry list of injuries - Dallas News

Click here to get full coverage on McLaren Will Return to Le Mans with the Mighty MCL-HY - Autoweek

McLaren Will Return to Le Mans with the Mighty MCL-HY  Autoweek

McLaren Will Return to Le Mans with the Mighty MCL-HY - Autoweek

Click here to get full coverage on FDA Approval of Brexu-Cel for R/R MCL Calls for Raised Awareness of CAR T-Cell Therapy Safety Considerations - OncLive

FDA Approval of Brexu-Cel for R/R MCL Calls for Raised Awareness of CAR T-Cell Therapy Safety Considerations  OncLive

FDA Approval of Brexu-Cel for R/R MCL Calls for Raised Awareness of CAR T-Cell Therapy Safety Considerations - OncLive

Click here to get full coverage on Dr Michael Wang Traces MCL Therapy Evolution Before CAR T - Targeted Oncology

Dr Michael Wang Traces MCL Therapy Evolution Before CAR T  Targeted Oncology

Dr Michael Wang Traces MCL Therapy Evolution Before CAR T - Targeted Oncology

Click here to get full coverage on McLaren names its forthcoming Hypercar the MCL-HY - RACER - Racing News

McLaren names its forthcoming Hypercar the MCL-HY  RACER - Racing News

McLaren names its forthcoming Hypercar the MCL-HY - RACER - Racing News

Click here to get full coverage on Serena Williams’ doubles partner Victoria Mboko to miss Wimbledon with knee injury - AP News

Serena Williams’ doubles partner Victoria Mboko to miss Wimbledon with knee injury  AP News

Serena Williams’ doubles partner Victoria Mboko to miss Wimbledon with knee injury - AP News

Click here to get full coverage on MCL Restaurants & Bakery closing several locations - Nation’s Restaurant News

MCL Restaurants & Bakery closing several locations  Nation’s Restaurant News

MCL Restaurants & Bakery closing several locations - Nation’s Restaurant News

Click here to get full coverage on Ushering in a New Combination-Driven Era in MCL - AJMC

Ushering in a New Combination-Driven Era in MCL  AJMC

Ushering in a New Combination-Driven Era in MCL - AJMC

Click here to get full coverage on Translational Research at ASH 2025 Illuminate Resistance, Risk Stratification in MCL - AJMC

Translational Research at ASH 2025 Illuminate Resistance, Risk Stratification in MCL  AJMC

Translational Research at ASH 2025 Illuminate Resistance, Risk Stratification in MCL - AJMC

Click here to get full coverage on Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL - OncLive

Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL  OncLive

Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL - OncLive

Click here to get full coverage on Brexu-Cel Secures Full FDA Approval in R/R MCL: Reflections From ZUMA-2 - Targeted Oncology

Brexu-Cel Secures Full FDA Approval in R/R MCL: Reflections From ZUMA-2  Targeted Oncology

Brexu-Cel Secures Full FDA Approval in R/R MCL: Reflections From ZUMA-2 - Targeted Oncology

Click here to get full coverage on McLaren MCL-HY – a name with a hint of promise for the 24 Hours of Le Mans - 24 Heures du Mans

McLaren MCL-HY – a name with a hint of promise for the 24 Hours of Le Mans  24 Heures du Mans

McLaren MCL-HY – a name with a hint of promise for the 24 Hours of Le Mans - 24 Heures du Mans

Click here to get full coverage on CAR T-Cell Therapy, BTK Inhibitors, and Bispecifics: The Various Paths Forward in MCL Research - OncLive

CAR T-Cell Therapy, BTK Inhibitors, and Bispecifics: The Various Paths Forward in MCL Research  OncLive

CAR T-Cell Therapy, BTK Inhibitors, and Bispecifics: The Various Paths Forward in MCL Research - OncLive

Click here to get full coverage on CHESS phase II: Zanubrutinib + rituximab followed by shortened chemoimmunotherapy in 1L MCL - Lymphoma Hub

CHESS phase II: Zanubrutinib + rituximab followed by shortened chemoimmunotherapy in 1L MCL  Lymphoma Hub

CHESS phase II: Zanubrutinib + rituximab followed by shortened chemoimmunotherapy in 1L MCL - Lymphoma Hub

Click here to get full coverage on FDA grants accelerated approval to sonrotoclax for R/R MCL - Lymphoma Hub

FDA grants accelerated approval to sonrotoclax for R/R MCL  Lymphoma Hub

FDA grants accelerated approval to sonrotoclax for R/R MCL - Lymphoma Hub

Click here to get full coverage on Maple Leafs' Auston Matthews (MCL surgery) facing 12-week recovery - ESPN

Maple Leafs' Auston Matthews (MCL surgery) facing 12-week recovery  ESPN

Maple Leafs' Auston Matthews (MCL surgery) facing 12-week recovery - ESPN

Click here to get full coverage on PROs Remain Consistent During Pirtobrutinib Treatment for CLL/MCL - OncLive

PROs Remain Consistent During Pirtobrutinib Treatment for CLL/MCL  OncLive

PROs Remain Consistent During Pirtobrutinib Treatment for CLL/MCL - OncLive

Click here to get full coverage on McLaren MCL-HY Hypercar breaks cover - RACER - Racing News

McLaren MCL-HY Hypercar breaks cover  RACER - Racing News

McLaren MCL-HY Hypercar breaks cover - RACER - Racing News

Click here to get full coverage on A McLAREN FAN'S GUIDE: MCL / COLLECT 2026 - McLaren.com

A McLAREN FAN'S GUIDE: MCL / COLLECT 2026  McLaren.com

MCL

Price Chart

Key Statistics

Technicals

About MCL

Latest News

Royals hold Witt Jr. (Grade 1 MCL sprain) out of lineup vs. Cardinals - MLB.com

Bobby Witt Jr. has a Grade 1 MCL sprain - Royals Review

Bobby Witt Jr. out of Royals' lineup with grade-1 MCL sprain - ESPN

Advanced Charts

Top Gainers

Top Losers